Akouos, Inc.
Clinical trials sponsored by Akouos, Inc., explained in plain language.
-
Gene therapy aims to restore hearing in children born deaf
⭐️ CURE ⭐️ Recruiting nowThis trial tests a one-time gene therapy for people with profound hearing loss caused by otoferlin gene mutations. A harmless virus delivers a working copy of the gene into the inner ear during surgery. The study includes 22 participants of any age and focuses on safety and wheth…
Phase: PHASE1, PHASE2 • Sponsor: Akouos, Inc. • Aim: ⭐️ CURE ⭐️
Last updated May 17, 2026 10:43 UTC
-
Experimental gene therapy targets hearing-loss tumors in early trial
Disease control Recruiting nowThis study tests a new gene therapy for people with a slow-growing tumor on the hearing nerve (vestibular schwannoma) that has caused severe hearing loss. The treatment is given as a single injection into the inner ear using a special device. The main goals are to check safety an…
Phase: PHASE1, PHASE2 • Sponsor: Akouos, Inc. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Scientists track rare genetic hearing loss to pave way for future treatments
Knowledge-focused Recruiting nowThis study follows up to 150 people with hearing loss caused by changes in the otoferlin gene. Researchers will measure hearing over time using tests like auditory brainstem response. No new treatment is given; the goal is to better understand how this type of hearing loss change…
Sponsor: Akouos, Inc. • Aim: Knowledge-focused
Last updated May 12, 2026 13:41 UTC